QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Macias-Gonzalez, M. Articles by Tinahones, F. J. Search for Related Content PubMed PubMed Citation Articles by Macias-Gonzalez, M. Articles by Tinahones, F. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ALANINE (L)-PROLINE Medline Plus Health Information Dietary Fats Metabolic Syndrome

---

Nutrition and Disease

PPAR mRNA Expression Is Reduced in Peripheral Blood Mononuclear Cells after Fat Overload in Patients with Metabolic Syndrome^1,2

⁴ CIBER Fisiopatología de la Obesidad y Nutrición, CB06/03, Instituto de Salud Carlos III, Madrid 28029, Spain; ⁵ Fundación IMABIS, Laboratorio de Investigación, Málaga 29010, Spain; and ⁶ Servicio de Endocrinología, Hospital Virgen de la Victoria, Málaga 29010, Spain

^* To whom correspondence should be addressed. E-mail: mmacias.manuel{at}gmail.com.

PPAR is a transcriptional regulator of metabolism; its activity can be modulated by direct binding of dietary lipids. The most prevalent human PPAR gene variant, Ala12, is associated with postprandial hypertriglyceridemia in patients with metabolic syndrome, although the mechanism whereby this polymorphism affects lipid homeostasis remains to be fully determined. Using peripheral blood mononuclear cells (PBMC), we studied the effect of the Pro12 and Ala12 polymorphisms on mRNA expression of PPAR and nuclear factor kappa B genes before and 3 and 4 h after fat overload. We also studied several biochemical and oxidative stress variables. Most of the indicators of oxidative stress were higher in patients with metabolic syndrome than in healthy subjects before and after fat overload. Patients also differed depending on whether they had the Pro12 or Ala12 variant in PBMC; PPAR expression was lower in healthy subjects compared with patients. After fat overload, circulating triglycerides and PPAR expression were positively correlated (r = 0.617, P < 0.05), and PPAR expression tended to be negatively correlated with 2 important markers of oxidative stress: plasma lipid peroxidation (r = –0.224, P < 0.1) and carbonylated proteins (CPro) (r = –0.340, P < 0.1) concentrations. We also found differences in several indicators of oxidative stress between Pro12 and Ala12 patients, including an increase in plasma CPro before and after fat overload in Ala12 but not Pro12 patients. These data provide evidence that the Ala12 sequence variant is associated with a worse metabolic profile than Pro12. This is related to differences in the expression of PPAR and to oxidative imbalance after fat overload.